Home/Filings/4/0001209191-15-000216
4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-15-000216

$TCRTCIK 0001107421operating

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:16 PM ET

Size

7.2 KB

Accession

0001209191-15-000216

Insider Transaction Report

Form 4
Period: 2014-12-30
LEWIS JONATHAN
DirectorCEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2014-12-31+350,000350,000 total
    Exercise: $5.07Exp: 2024-12-30Common Stock (350,000 underlying)
  • Tax Payment

    Common Stock

    2014-12-30$5.03/sh34,261$172,333744,145 total
Footnotes (2)
  • [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
  • [F2]116,666 shares shall vest on 12/31/2015; and 116,667 shares shall vest on each of 12/31/2016 and 12/31/2017.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001107421

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:16 PM ET
Size
7.2 KB